Skip to content
    SV Health Investors logo

    SV Health Investors

    Boston, Massachusetts, United StatesFounded 1993
    svhealthinvestors.comLinkedIn
    Biotech & Life SciencesHealthcareFintech

    SV Health Investors is a specialist healthcare fund manager that invests across multiple stages and sectors, utilizing strategy-specific funds. Their investment focus spans therapeutics (including biotechnology and dementia), healthcare growth, and medtech, aiming to identify and support promising healthcare ventures.

    64% of their portfolio is in Biotech & Life Sciences. Deal activity increased 33% year-over-year (4 deals in the last 12 months). Average disclosed round size is $57.0M (across 14 rounds with reported amounts).

    Find people at SV Health Investors on Goldilocks AI

    Portfolio

    14

    Fund Size

    $4B

    Top Stage

    Series B

    Last 12 Mo

    4

    Team

    NT

    Nikola Trbovic

    Managing Partner

    AS

    Aaron Sandoski

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    14 investments
    CompanyRoundAmountDate
    Mestag Therapeutics logoMestag TherapeuticsSeries B$40MMar 2026
    TTRexBioSeries C$50MJan 2026
    Artios Pharma Limited logoArtios Pharma LimitedSeries D$115MNov 2025
    Dualitas Therapeutics, Inc. logoDualitas Therapeutics, Inc.Series A$65MSep 2025
    Imbria Pharmaceuticals logoImbria PharmaceuticalsSeries B$57.5MApr 2025
    CCSA Medical Inc.Series D$53MSep 2024
    BBrixton BiosciencesSeries B$33MMay 2024
    CarePredict logoCarePredictSeries A$29MJul 2023
    HHealth Payment Systems, Inc. (HPS)/PayMedixGrowth$25MJan 2023
    Ria Health logoRia HealthSeries A$18MJun 2022
    Artios Pharma Limited logoArtios Pharma LimitedSeries C$153MJul 2021
    Sitryx Therapeutics logoSitryx TherapeuticsSeries A$30MOct 2018
    Endotronix, Inc. logoEndotronix, Inc.Series D$45MSep 2018
    Artios Pharma Limited logoArtios Pharma LimitedSeries B$84MAug 2018

    Top Co-Investors

    Pfizer Ventures4 shared
    Andera Partners3 shared
    LSP3 shared
    Novartis Venture Fund3 shared
    M Ventures3 shared
    Sofinnova Partners3 shared
    Deep Track Capital2 shared
    RA Capital Management2 shared
    Omega Funds2 shared
    Avidity Partners2 shared
    Invus2 shared
    Schroders Capital2 shared
    Eli Lilly and Company2 shared
    Alexandria Venture Investments2 shared
    Janus Henderson Investors2 shared
    Silicon Valley Bank1 shared
    Ascension Ventures1 shared
    Blue Heron Capital1 shared
    TVM Capital Life Science1 shared
    First Analysis1 shared

    Last updated: 28 April 2026